Triple

Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).

Phrase: WHO technical documentation on ATC/DDD system | Statement: [WHO Collaborating Centre for Drug Statistics Methodology, subjectOf, WHO technical documentation on ATC/DDD system]

Target entity: WHO technical documentation on ATC/DDD system
Context triple: [WHO Collaborating Centre for Drug Statistics Methodology, subjectOf, WHO technical documentation on ATC/DDD system]

• A. WHO Collaborating Centre for Drug Statistics Methodology chosen
  The WHO Collaborating Centre for Drug Statistics Methodology is a specialized World Health Organization center responsible for developing and maintaining international standards for drug classification and consumption statistics, including the ATC/DDD system.
• B. World Health Organization Model List of Essential Medicines
  The World Health Organization Model List of Essential Medicines is a periodically updated catalog of the most effective, safe, and cost-efficient medicines deemed essential for meeting the priority health needs of populations worldwide.
• C. WHO Expert Committee on Selection and Use of Essential Medicines
  The WHO Expert Committee on Selection and Use of Essential Medicines is a specialized World Health Organization body that evaluates evidence and advises which medicines should be prioritized globally for inclusion on the Model List of Essential Medicines.
• D. Anatomical Therapeutic Chemical Classification System
  The Anatomical Therapeutic Chemical Classification System is an internationally used drug classification system that organizes medicines into groups according to the organ or system they act on and their therapeutic and chemical characteristics.
• E. Pharmacovigilance Risk Assessment Committee within the European Medicines Agency
  The Pharmacovigilance Risk Assessment Committee within the European Medicines Agency is an expert body responsible for evaluating and monitoring the safety of medicines across the European Union and providing recommendations on managing and communicating medicine-related risks.
• F. None of above.
• G. Unsure - the case is ambiguous/there is not enough information to decide.